RxDoctor Payments Data

Rasheed Onafuye

Geriatric Psychiatry · Monroe, NCNPI 1669651667

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,822 of the $2,695 with a category attached, or 67.6%. Neuronetics, Inc. accounts for 71.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $1,883 and has fallen 81.9% since, to $341 in 2025.

$2,695in general payments, 2019–2025

Across 32 payments — averaging $84.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neuronetics, Inc.$2K
  • Amgen$242
  • Johnson & Johnson$106
  • Supernus Pharmaceuticals, Inc.$95
  • AbbVie$86
  • Otsuka America Pharmaceutical, Inc.$61
  • plus $185 from 6 others
$3,196,488in research payments, 2019–2025

Across 406 payments — averaging $7873.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Indivior Inc.$3M
  • Janssen Research & Development, LLC$111K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$52K
  • AbbVie$7K

What the payments were for

  • Travel & lodging$87332%
  • Food & beverage$1,82268%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few geriatric psychiatry providers in North Carolinato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine Hcl70$3,670
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine25$1,178
Fluoxetine Hcl46$683
Clonazepam61$501
Lamotrigine31$269
Bupropion Hcl SrBupropion Hcl18$167
Zolpidem Tartrate17$157
Temazepam12$154
Alprazolam16$153
Gabapentin13$75
Venlafaxine Hcl ErVenlafaxine Hcl12$72
Diazepam14$68
Citalopram HbrCitalopram Hydrobromide12$45
Topiramate12$44
Trazodone Hcl15$43

Paid to pharmacies, not to this prescriber.

Other geriatric psychiatry in Monroe

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →